Ali Behbahani's Net Worth
$131 Million
Who is Ali Behbahani?
Ali Behbahani has an estimated net worth of $131 Million. This is based on reported shares across multiple companies, which include Nkarta, Inc., Bright Health Group Inc., Monte Rosa Therapeutics, Inc., Oyster Point Pharma, Inc., NEVRO CORP, Mirum Pharmaceuticals, Inc., Adaptimmune Therapeutics PLC, CRISPR Therapeutics AG, GENOCEA BIOSCIENCES, INC., Metacrine, Inc., CVRx, Inc., Arcellx, Inc., Savara Inc, Trevi Therapeutics, Inc., MINERVA SURGICAL INC, Akouos, Inc., Black Diamond Therapeutics, Inc., Arsanis, Inc., Regulus Therapeutics Inc., Marker Therapeutics, Inc., and Korro Bio, Inc..
SEC CIK
Ali Behbahani's CIK is 0001613867
Past Insider Trading and Trends
2021 was Ali Behbahani's most active year for acquiring shares with 38 total transactions. Ali Behbahani's most active month to acquire stocks was the month of May. 2021 was Ali Behbahani's most active year for disposing of shares, totalling 21 transactions. Ali Behbahani's most active month to dispose stocks was the month of May. 2022 saw Ali Behbahani paying a total of $350,368,747.88 for 7,821,913 shares, this is the most they've acquired in one year. In 2022 Ali Behbahani cashed out on 14,671,143 shares for a total of $750,662.12, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nkarta, Inc. (NKTX) Snapshot price: $10.26
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
NeueHealth, Inc. (BHG) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
∞
| 71.91M |
$18.00 |
—
| 71.91M |
Jun 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Monte Rosa Therapeutics, Inc. (GLUE) Snapshot price: $4.72
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
∞
| 7.69M |
$19.00 |
—
| 7.69M |
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Oyster Point Pharma, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -13.64K |
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +35.50% | 3.57K |
—
|
—
| 13.64K |
Jun 6
| |||
Form 4
| +52.52% | 3.47K |
—
|
—
| 10.07K |
Jun 7
| |||
Form 4
|
∞
| 6.6K |
—
|
—
| 6.6K |
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
NEVRO CORP (NVRO) Snapshot price: $17.11
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +235.83% | 3.79K |
—
|
—
| 5.39K |
May 21
| |||
Form 4
| +2.56% | 40 |
—
|
—
| 1.6K |
Sep 14
| |||
Form 4
| +3,229.79% | 1.52K |
—
|
—
| 1.56K |
May 25
| |||
Form 4
| +88.00% | 22 |
—
|
—
| 47 |
Nov 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
∞
| 25 |
—
|
—
| 25 |
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |